Mark J. Gergen, Executive VP, COO at Mirati Therapeutics, Inc. (MRTX), sold 10,000 shares at $25.92 ($259K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $259k MRTX by Executive VP, COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRTX | SELL | 2016-01-19 | $518K | — | Filing → |
| AMLN | SELL | 2012-03-02 | $32K | — | Filing → |
| AMLN | SELL | 2012-02-24 | $128K | — | Filing → |